Late results following rifampicin therapy and tolerance of rifampicin given on a long-term basis.
D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000150:complications; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D002908:Chronic Disease; D004338:Drug Combinations; D005500:Follow-Up Studies; D006801:Humans; D007565:Jaundice / Q000209:etiology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008107:Liver Diseases / Q000503:physiopathology; D008111:Liver Function Tests; D011859:Radiography; D012293:Rifampin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D004338:Drug Combinations; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin; D012293:Rifampin